Tricyclic Antidepressants on Gemini 5u C18
LC Conditions
Column
Gemini 5 µm C18 110 Å, LC Column 150 x 4.6 mm, Ea
Brand
Gemini
Part No
00F-4435-E0
Phase Name
C18
Elution Type
Isocratic
Mobile Phase
A: 20mM Phosphate buffer, pH 7
B: Acetonitrile
C: Methanol
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
30
35
Flow Rate
1.50 mL/min
Temperature
22°C
Detection
UV-Vis Abs.-Variable Wave.(UV) @ (22°C)
Detection Info
Sample Notes
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, Gemini C18 4 x 3.0mm, 10/Pk Part No.: AJ0-7597 - Holder Part No.: KJ0-4282
Order Items Used in This Application
- 1. Nortriptyline
- 2. Imipramine
- 3. Amitriptyline
- 4. Clomipramine
-OEChem-06211003152D<br><br> 41 43 0 0 0 0 0 0 0999 V2000<br> 3.1509 -2.0953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.3830 3.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.3830 3.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7595 2.3135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0065 2.3135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8830 0.9047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.9820 1.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.7840 1.3385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8830 -0.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.7690 2.6358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.9970 2.6358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.2295 0.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.5365 0.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.0170 -0.5953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 1.9333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7660 1.9332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.0169 -1.5953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.2318 0.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.5342 0.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1509 -3.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5210 3.6998 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.8244 3.3643 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.9416 3.3643 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.2450 3.6998 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4199 -0.4053 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.6380 3.2418 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.1280 3.2418 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.3744 0.0156 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3916 0.0155 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.8049 -0.0127 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.4064 -0.7030 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2290 -2.1779 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.6275 -1.4877 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.4083 2.1183 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 8.3578 2.1182 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.7789 0.4943 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.9871 0.4942 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.6140 -1.7853 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.5309 -3.0953 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1509 -3.7153 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7709 -3.0953 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 17 1 0 0 0 0<br> 1 20 1 0 0 0 0<br> 1 38 1 0 0 0 0<br> 2 3 1 0 0 0 0<br> 2 4 1 0 0 0 0<br> 2 21 1 0 0 0 0<br> 2 22 1 0 0 0 0<br> 3 5 1 0 0 0 0<br> 3 23 1 0 0 0 0<br> 3 24 1 0 0 0 0<br> 4 7 1 0 0 0 0<br> 4 10 2 0 0 0 0<br> 5 8 1 0 0 0 0<br> 5 11 2 0 0 0 0<br> 6 7 1 0 0 0 0<br> 6 8 1 0 0 0 0<br> 6 9 2 0 0 0 0<br> 7 12 2 0 0 0 0<br> 8 13 2 0 0 0 0<br> 9 14 1 0 0 0 0<br> 9 25 1 0 0 0 0<br> 10 15 1 0 0 0 0<br> 10 26 1 0 0 0 0<br> 11 16 1 0 0 0 0<br> 11 27 1 0 0 0 0<br> 12 18 1 0 0 0 0<br> 12 28 1 0 0 0 0<br> 13 19 1 0 0 0 0<br> 13 29 1 0 0 0 0<br> 14 17 1 0 0 0 0<br> 14 30 1 0 0 0 0<br> 14 31 1 0 0 0 0<br> 15 18 2 0 0 0 0<br> 15 34 1 0 0 0 0<br> 16 19 2 0 0 0 0<br> 16 35 1 0 0 0 0<br> 17 32 1 0 0 0 0<br> 17 33 1 0 0 0 0<br> 18 36 1 0 0 0 0<br> 19 37 1 0 0 0 0<br> 20 39 1 0 0 0 0<br> 20 40 1 0 0 0 0<br> 20 41 1 0 0 0 0<br>M END
Compound Name
Nortriptyline
CID
4543
Molecular Formula
C19H21N
Molecular Weight
263
No. Hydrogen Bond Acceptors
1
No. Hydrogen Bond Donors
1
Similar Applications
Reversed Phase
ABN3 mix on Luna Omega 5 µm C18 250x4.6mm (Batch 3) using Agilent 1260 Binary UHPLC system
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
26496
Reversed Phase
ABN3 mix on Luna Omega 5 µm C18 250x4.6mm (Batch 2) using Agilent 1260 Binary UHPLC system
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
26495
Reversed Phase
ABN3 mix on Luna Omega 5 µm C18 250x4.6mm (Batch 1) using Agilent 1260 Binary UHPLC system
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
26494
Reversed Phase
ABN3 mix on Luna Omega 3 µm C18 150x4.6mm (Batch 3) using Agilent 1260 Binary UHPLC system
Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
26487
Reversed Phase
ABN3 mix on Luna Omega 3 µm C18 150x4.6mm (Batch 2) using Agilent 1260 Binary UHPLC system
Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
26486
Reversed Phase
ABN3 mix on Luna Omega 3 µm C18 150x4.6mm (Batch 1) using Agilent 1260 Binary UHPLC system
Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
26485
Reversed Phase
ABN3 mix on Luna Omega 1.6 µm C18 50x2.1mm (Batch 3) using Agilent 1260 Binary UHPLC system
Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA
26478
Reversed Phase
ABN3 mix on Luna Omega 1.6 µm C18 50x2.1mm (Batch 2) using Agilent 1260 Binary UHPLC system
Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA
26477
Reversed Phase
ABN3 mix on Luna Omega 1.6 µm C18 50x2.1mm (Batch 1) using Agilent 1260 Binary UHPLC system
Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA
26476
Reversed Phase
Fast Screening Method for 86 Forensic Analytes in Human Urine by LC-MS/MS
Luna 5 µm C18(2) 100 Å, LC Column 50 x 2 mm, Ea
25864
Reversed Phase
Tricyclic Antidepressants Panel by LC-MS/MS with Kinetex 2.6 um PS C18
Kinetex 2.6 µm PS C18 100 Å, LC Column 100 x 2.1 mm, Ea
25493
Reversed Phase
TCAs on Luna Omega 3u PS C18 100x4.6mm
Luna Omega 3 µm PS C18 100 Å, LC Column 100 x 4.6 mm, Ea
24052
Reversed Phase
ABN7 on Luna Omega 1.6u PS C18 50x2.1mm
Luna Omega 1.6µm PS C18 100Å, LC Column 50 x 2.1 mm, EA
23707
Reversed Phase
7.5 min Pain Panel on Kinetex 2.6µm Biphenyl, 30x2.1mm ESI+
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 30 x 2.1 mm, Ea
23560
Reversed Phase
Fast Pain Panel ESI+
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 30 x 2.1 mm, Ea
23384
Reversed Phase
ABN6 Mix on Kinetex 1.7u EVO C18 50x2.1mm
Kinetex 1.7 µm EVO C18 100 Å, LC Column 50 x 2.1 mm, Ea
23068
Reversed Phase
Batch Reproducibility with ABN 7 mix- Kinetex 2.6u F5 50x4.6mm
Kinetex 2.6 µm F5 100 Å, LC Column 50 x 4.6 mm, Ea
22803
Reversed Phase
TCAs at neutral pH Kinetex 5u EVO C18 150x4.6mm
Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea
22779
Reversed Phase
Analytical loading study using Kinetex 5u EVO C18 150x4.6mm
Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea
22737
Reversed Phase
Batch reproducibility of Kinetex 5u EVO C18 150x4.6mm
Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea
22734
Reversed Phase
Pharma ABN Mixture using Kinetex 5u EVO C18 150x4.6mm
Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea
22718
Reversed Phase
Pharma ABN Test 15 Mix on Waters Acquity UPLC using Kinetex 1.7u C18 100x2.1mm @ 0.60mL/min
Kinetex 1.7 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
20054
Reversed Phase
Pharma ABN Test 15 Mix on Waters Acquity UPLC using Kinetex 2.6u C18 100x2.1mm @ 0.60mL/min
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
20053
Reversed Phase
Pharma ABN Test 15 Mix on Waters Acquity UPLC using Kinetex 2.6 C18 100x2.1mm @ 1.0mL/min
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
20050
Reversed Phase
Pharma ABN Test 15 Mix on Un-Optimized Agilent 1100 system using Kinetex 2.6u C18 100x4.6mm
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
20049
Reversed Phase
Pharma ABN Test 15 Mix on Optimized Agilent 1100 system using Kinetex 2.6u C18 100x4.6mm
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
20048
Reversed Phase
Pharmaceutical Drug Mix on Kinetex C18 2.6u 100 x 2.1mm @ 0.85 mL/min(Quotient Data)
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
19940
Reversed Phase
Pharmaceutical Drug Mix on Kinetex C18 2.6u 75 x 2.1mm @ 1.1 mL/min(Quotient Data)
Kinetex 2.6 µm C18 100 Å, LC Column 75 x 2.1 mm, Ea
19939
Reversed Phase
Pharmaceutical Drug Mix on Kinetex 2.6 µm C18 50 x 2.1mm @ 0.8 mL/min(Quotient Data)
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19911
Reversed Phase
Pharmaceutical Drug Mix on Kinetex C18 2.6u 50 x 2.1mm @ 1.4 mL/min(Quotient Data)
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19862
Reversed Phase
Pharmaceutical Mixture on Kinetex 2.6µm C8 50x2.1mm ID
Kinetex 2.6 µm C8 100 Å, LC Column 50 x 2.1 mm, Ea
19476
Reversed Phase
Pharmaceutical Mixture on Kinetex XB-C18
Kinetex 2.6 µm XB-C18 100 Å, LC Column 50 x 2.1 mm, Ea
19475
Reversed Phase
Pharmaceutical Mixture on Kinetex C18
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19474
Reversed Phase
TCA's UV Kinetex 1.7µm C18 50x2.1mm Acquity UPLC
Kinetex 1.7 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19310
Reversed Phase
TCA's LC/MS/MS Kinetex 1.7µm C18 50x2.1mm Agilent 1200
Kinetex 1.7 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19309
Reversed Phase
TCA's LC/MS/MS Kinetex 1.7µm C18 50x2.1mm Agilent 1200
Kinetex 1.7 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19308
Reversed Phase
TCA's LC/MS/MS Kinetex 1.7µm C18 50x2.1mm Agilent 1200
Kinetex 1.7 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19307
Reversed Phase
TCA's LC/MS/MS Kinetex 1.7µm C18 50x2.1mm Agilent 1200
Kinetex 1.7 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19306
Standard
Antidepressants (Underivatized) on ZB-1701, 15 m x 0.25 mm x 0.25 µm
Zebron ZB-1701, GC Cap. Column 15 m x 0.25 mm x 0.25 µm, Ea
19295
Reversed Phase
Competitor Comparison-Tricyclic Antideprassent on Kinetex 2.6 µm C18 100 x 4.6mm
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
19230
Reversed Phase
MercuryMS - Luna 3µm C18(2) 20 x 2.0mm (mini column) for Tricyclics in Plasma by LC/MS/MS
Luna 3 µm C18(2) 100 Å, LC Column 20 x 2 mm, Ea
16043
MercuryMS - Synergi 2.5µm Fusion-RP 20 x 2.0mm for Tricyclics in Plasma by LC/MS/MS
16041